Nexrami 1.25mg Tablet
By Nexrami
Rx
10 Tablet in a Strip

Composition
Ramipril(1.25mg)

Manufacturer - Nexus Biotech
NEXUS HOUSE # 19, 1ST FLOOR & 2ND FLOOR, 6TH MAIN, HANUMANTH NAGAR 2ND BLOCK, BSK 1st STAGE, 50 FT ROAD, Bangalore - 560050, Karnataka, India

Expires on or after
September, 2025

liver
When taking Nexrami 1.25mg Tablet, it is essential to be cautious if you have liver disease. In such cases, your doctor may need to adjust the dose of the medication. Make sure to inform your doctor if you notice any signs or symptoms of jaundice while using Nexrami 1.25mg Tablet. It is advisable to seek medical advice and supervision to ensure the safety and effectiveness of the treatment in relation to liver health.

kidney
Nexrami 1.25mg Tablet should be used carefully in patients with kidney disease. Adjusting the dose may be necessary, so consult your doctor. Regularly monitor blood pressure for dose adjustments.

alcohol
Nexrami 1.25mg Tablet can lead to increased drowsiness when taken with alcohol. It is important to be cautious when consuming alcohol while on this medication.

driving
Nexrami 1.25mg Tablet may reduce alertness, impact vision, or cause drowsiness and dizziness. Avoid driving if experiencing these symptoms.

pregnancy
Nexrami 1.25mg Tablet is not recommended during pregnancy due to potential risk to the baby. In rare life-threatening cases, a doctor may prescribe it if benefits outweigh risks. Always consult your doctor.

breastfeeding
Nexrami 1.25mg Tablet is considered unsafe during breastfeeding. Limited human data indicates potential transfer of the drug into breastmilk, posing a risk to the baby.
Habit Forming | No |
Chemical Class | Dipeptides (Carboxylic acids derivatives) |
Therapeutic Class | CARDIAC |
Action Class | Angiotensin-converting enzyme (ACE) inhibitors |
₹29
Inclusive of all taxes
Content verified by

Dr. Archana Prabhakar
MBBS, M.Med (Family Medicine)
Last update on 01-Oct-2024